Amgen Inc vs. Surrozen, Inc. Common
Amgen Inc (AMGN) comes out ahead, leading on 5 of 8 compared factors.
Size & Scale
| AMGN | SRZN | |
|---|---|---|
| Market Cap | $219.55 billion | $189.94 million |
| Revenue (TTM) | $38.09 billion | $11.51 million |
| Net Income (TTM) | $8.74 billion | $-332,130,000 |
AMGN leads on 3 of 3 size & scale factors.
Valuation
| AMGN | SRZN | |
|---|---|---|
| P/E Ratio | 25.22 | — |
| Price / Book | 18.78 | -0.87 |
| Price / Sales | 5.76 | 16.50 |
AMGN and SRZN split the valuation factors evenly.
Profitability
| AMGN | SRZN | |
|---|---|---|
| Net Margin | 22.95% | -2885.33% |
| Return on Equity | 74.80% | 151.89% |
AMGN and SRZN split the profitability factors evenly.
Dividend
| AMGN | SRZN | |
|---|---|---|
| Dividend Yield | 2.48% | — |
| Payout Ratio | 62.61 | — |
AMGN and SRZN split the dividend factors evenly.
Risk & Sentiment
| AMGN | SRZN | |
|---|---|---|
| Short Interest | 1.66% | 0.33% |
SRZN leads on 1 of 1 risk & sentiment factors.
Dig deeper: AMGN overview, AMGN financials, SRZN overview, SRZN financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.